Evaluation of the safety and pathological effects of neoadjuvant full-dose gemcitabine combination radiation therapy in patients with biliary tract cancer
Conclusions
Neoadjuvant therapy was feasible and is expected to improve survival by controlling regional extension.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Bile | Bile Duct Cancer | Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Cholangiocarcinoma | Drugs & Pharmacology | Gallbladder Cancer | Hematology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Radiation Therapy | Study | Thrombocytopenia